Literature DB >> 18535600

Graves' orbitopathy: frequency of ocular hypertension and glaucoma.

F L M da Silva1, M de Lourdes Veronese Rodrigues, P M S Akaishi, A A V Cruz.   

Abstract

PURPOSE: To determine the relationship between ocular hypertension and glaucoma in patients with Graves' orbitopathy.
METHODS: A total of 107 patients with a diagnosis of Graves' orbitopathy, followed at the Oculoplasty sector of the University Hospital, Medical School of Ribeirão Preto, were evaluated by applanation tonometry, computed visual campimetry (Humphrey 30-2, Full Threshold) and analysis and photographic documentation of the optic nerve. The patients considered to have the suspicion of glaucoma were re-evaluated 1 year later for diagnostic confirmation or exclusion.
RESULTS: A 3.74% prevalence of ocular hypertension (four patients) and a 2.8% prevalence of glaucoma (three patients) was observed. When considering only patients older than 40 years, the prevalence of ocular hypertension was 5.4% (four patients) and the prevalence of glaucoma was 4.76% (three patients).
CONCLUSION: The present study did not reveal a statistically significant difference in the prevalence of ocular hypertension or glaucoma between patients with Graves' orbitopathy and the general population.

Entities:  

Mesh:

Year:  2008        PMID: 18535600     DOI: 10.1038/eye.2008.155

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  3 in total

1.  Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy.

Authors:  K A Ponto; T Diana; H Binder; N Matheis; S Pitz; N Pfeiffer; G J Kahaly
Journal:  J Endocrinol Invest       Date:  2015-03-04       Impact factor: 4.256

2.  Prevalence of increased intraocular pressure in patients with Graves' ophthalmopathy and association with ophthalmic signs and symptoms in the north-west of Iran.

Authors:  Fatemeh Eslami; Shiva Borzouei; Elham Khanlarzadeh; Shiva Seif
Journal:  Clin Ophthalmol       Date:  2019-07-25

3.  Topical Treatment of Elevated Intraocular Pressure in Patients with Graves' Orbitopathy.

Authors:  Magdalena Gumińska; Roman Goś; Janusz Śmigielski; Michał S Nowak
Journal:  Int J Environ Res Public Health       Date:  2020-12-13       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.